Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.

BACKGROUND Limited data are available on the impact of time to ICU admission and outcomes for patients with severe community acquired pneumonia (CAP). Our objective was to examine the association of time to ICU admission and 30-day mortality in patients with severe CAP. METHODS A retrospective cohort study of 161 ICU subjects with CAP (by International Classification of Diseases, 9th edition, codes) was conducted over a 3-year period at two tertiary teaching hospitals. Timing of the ICU admission was dichotomized into early ICU admission (EICUA, direct admission or within 24 h) and late ICU admission (LICUA, >or= day 2). A multivariable analysis using Cox proportional hazard model was created with the primary outcome of 30-day mortality (dependent measure) and the American Thoracic Society (ATS) severity adjustment criteria and time to ICU admission as the independent measures. RESULTS Eighty-eight percent (n = 142) were EICUA patients compared with 12% (n = 19) LICUA patients. Groups were similar with respect to age, gender, comorbidities, clinical parameters, CAP-related process of care measures, and need for mechanical ventilation. LICUA patients had lower rates of ATS severity criteria at presentation (26.3% vs 53.5%; P = .03). LICUA patients (47.4%) had a higher 30-day mortality compared with EICUA (23.2%) patients (P = .02), which remained after adjusting in the multivariable analysis (hazard ratio 2.6; 95% CI, 1.2-5.5; P = .02). CONCLUSION Patients with severe CAP with a late ICU admission have increased 30-day mortality after adjustment for illness severity. Further research should evaluate the risk factors associated and their impact on clinical outcomes in patients admitted late to the ICU.

[1]  J. Rello,et al.  Severity of pneumococcal pneumonia associated with genomic bacterial load. , 2009, Chest.

[2]  J. Rello Demographics, guidelines, and clinical experience in severe community-acquired pneumonia , 2008, Critical care.

[3]  Rory Wolfe,et al.  SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Jiaquan Xu,et al.  Deaths: final data for 2005. , 2008, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[5]  A. Anzueto,et al.  A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. , 2008, Chest.

[6]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Ortega,et al.  Development and validation of a clinical prediction rule for severe community-acquired pneumonia. , 2006, American journal of respiratory and critical care medicine.

[8]  L. Kozak,et al.  National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.

[9]  A. Anzueto,et al.  COPD is associated with increased mortality in patients with community-acquired pneumonia , 2006, European Respiratory Journal.

[10]  J. Rello,et al.  Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia , 2006, European Respiratory Journal.

[11]  B. Guery,et al.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit , 2006, Intensive Care Medicine.

[12]  D. Thévenin,et al.  Severe community-acquired pneumonia in ICUs: Prospective validation of a prognostic score , 1996, Intensive Care Medicine.

[13]  M. Niederman,et al.  Validation of predictive rules and indices of severity for community acquired pneumonia , 2004, Thorax.

[14]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[15]  Gilles Clermont,et al.  Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. , 2002, American journal of respiratory and critical care medicine.

[16]  M. Fine,et al.  Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. , 2002, Archives of internal medicine.

[17]  J. Rello,et al.  Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia , 2002, Intensive Care Medicine.

[18]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[19]  W. Lim,et al.  Severity prediction rules in community acquired pneumonia: a validation study , 2000, Thorax.

[20]  C. VandenBussche,et al.  Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia , 1999, Intensive Care Medicine.

[21]  A. Torres,et al.  Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. , 1999, American journal of respiratory and critical care medicine.

[22]  M. Niederman,et al.  Severe community-acquired pneumonia. Assessment of severity criteria. , 1998, American journal of respiratory and critical care medicine.

[23]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[24]  J. Rello,et al.  Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  S. Chevret,et al.  Severe Community-Acquired Pneumonia: Etiology, Epidemiology, and Prognosis Factors , 1994 .

[26]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[27]  P. Grambsch,et al.  Martingale-based residuals for survival models , 1990 .

[28]  L. Cancio,et al.  PIRO score for community-acquired pneumonia : A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia To the , 2022 .